Drugs / LUCAR-G79 T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07049081 | Jul 2025 → Mar 2026 | — | Nanjing Legend Biotech Co. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LUCAR-G79 T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07049081 ↗ |
| Modality | Cell therapy | “a chimeric antigen receptor (CAR) -T cell therapy” NCT07049081 ↗ |
| Route | Other | “LUCAR-G79 infusion” NCT07049081 ↗ |